An Entity of Type: Thing, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

COVID-19 vaccination in Taiwan is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country. Following the approval of the Oxford–AstraZeneca COVID-19 vaccine on 18 March 2021, vaccinations commenced on 22 March 2021, and will continue throughout the year with the goal of vaccinating 70% of the population by late October 2021.

Property Value
dbo:abstract
  • COVID-19 vaccination in Taiwan is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country. Following the approval of the Oxford–AstraZeneca COVID-19 vaccine on 18 March 2021, vaccinations commenced on 22 March 2021, and will continue throughout the year with the goal of vaccinating 70% of the population by late October 2021. As of 21 October 2022, 21,761,873 people, or 93.81% of the Taiwanese population has received at least one dose, while 20,447,829 people, or 88.14% of the population have received at least two doses, while 17,102,993, or 73.73% of the population have received at least three, while 3,300,926 people, or 14.23% of the population having received at least four, and 249,559 people, or 1.1% of the population, having received all five. A further 185,463 immunocompromised individuals, or 0.8% of the population, have received a weakened version of the booster dose. 93.96% of those over 12 have received the first booster dose, while 41.4% of those over 65 have received the second booster dose. (en)
  • La campagne de vaccination contre la Covid-19 à Taïwan vise la maladie à coronavirus 2019, en réponse à la pandémie de Covid-19 active depuis le 21 janvier 2020 sur le territoire national. (fr)
  • Vaksinasi COVID-19 di Taiwan adalah sebuah kampanye imunisasi terkini melawan (SARS-CoV-2), dalam menanggapi pandemi yang terjadi di Taiwan. Setelah penyetujuan vaksin COVID-19 Oxford–AstraZeneca pada 18 Maret 2021, vaksinasi dilakukan pada 22 Maret 2021, dan akan dilanjutkan sepanjang tahun dengan tujuan memvaksinasi 60% populasi pada Oktober 2021. (in)
  • 臺灣嚴重特殊傳染性肺炎疫苗接種計畫是指中華民國在2019冠狀病毒病臺灣疫情期間的疫苗接種計畫。 (zh)
dbo:thumbnail
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 67872083 (xsd:integer)
dbo:wikiPageLength
  • 60471 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1124104015 (xsd:integer)
dbo:wikiPageWikiLink
dbp:budget
  • 18700000000 (xsd:decimal)
dbp:caption
  • 0001-05-02 (xsd:gMonthDay)
  • 0001-07-31 (xsd:gMonthDay)
  • Man receiving a COVID-19 vaccine shot in a vaccination center in Hsinchu, Taiwan. (en)
dbp:cause
dbp:color
  • lightblue (en)
  • lightgreen (en)
  • gainsboro (en)
  • plum (en)
  • salmon (en)
  • magenta (en)
  • steelblue (en)
  • greenyellow (en)
dbp:date
  • 2021-03-22 (xsd:date)
dbp:label
  • Population that have received two booster doses : 1,687,207 (en)
  • Population that have received 1 booster dose : 14,859,353 (en)
  • AstraZeneca COVID-19 vaccine (en)
  • Medigen Biologics COVID-19 vaccine (en)
  • Moderna COVID-19 vaccine (en)
  • Pfizer-BioNTech COVID-19 vaccine (en)
  • Population that have received 2 doses: 3,368,689 (en)
  • Population who have received 1 dose: 1,401,521 (en)
  • Unvaccinated population: 1,869,508 (en)
dbp:organizers
dbp:outcome
  • 17.300000 (xsd:double)
  • 74 (xsd:integer)
  • 88.600000 (xsd:double)
  • 94 (xsd:integer)
  • 0001-11-27 (xsd:gMonthDay)
dbp:participants
  • 4018016 (xsd:integer)
  • 17220124 (xsd:integer)
  • 20546190 (xsd:integer)
  • 21802750 (xsd:integer)
  • 0001-10-21 (xsd:gMonthDay)
dbp:target
  • Immunization against COVID-19 (en)
dbp:title
  • COVID-19 vaccination in Taiwan (en)
dbp:value
  • 4.890000 (xsd:double)
  • 6 (xsd:integer)
  • 7.300000 (xsd:double)
  • 8.100000 (xsd:double)
  • 14.500000 (xsd:double)
  • 29.030000 (xsd:double)
  • 29.800000 (xsd:double)
  • 36.280000 (xsd:double)
  • 64.100000 (xsd:double)
dbp:wikiPageUsesTemplate
dct:subject
rdfs:comment
  • La campagne de vaccination contre la Covid-19 à Taïwan vise la maladie à coronavirus 2019, en réponse à la pandémie de Covid-19 active depuis le 21 janvier 2020 sur le territoire national. (fr)
  • Vaksinasi COVID-19 di Taiwan adalah sebuah kampanye imunisasi terkini melawan (SARS-CoV-2), dalam menanggapi pandemi yang terjadi di Taiwan. Setelah penyetujuan vaksin COVID-19 Oxford–AstraZeneca pada 18 Maret 2021, vaksinasi dilakukan pada 22 Maret 2021, dan akan dilanjutkan sepanjang tahun dengan tujuan memvaksinasi 60% populasi pada Oktober 2021. (in)
  • 臺灣嚴重特殊傳染性肺炎疫苗接種計畫是指中華民國在2019冠狀病毒病臺灣疫情期間的疫苗接種計畫。 (zh)
  • COVID-19 vaccination in Taiwan is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country. Following the approval of the Oxford–AstraZeneca COVID-19 vaccine on 18 March 2021, vaccinations commenced on 22 March 2021, and will continue throughout the year with the goal of vaccinating 70% of the population by late October 2021. (en)
rdfs:label
  • COVID-19 vaccination in Taiwan (en)
  • Vaksinasi Covid-19 di Taiwan (in)
  • Campagne de vaccination contre la Covid-19 à Taïwan (fr)
  • 臺灣嚴重特殊傳染性肺炎疫苗接種計畫 (zh)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License